Expanding Sales in Advanced Markets
First written in FY2016-Q3. 11 of 24 entries say "Restated". Latest entry: 2026-07-15.
The whole theme swung hardest in 2026: 1 of 6 companies on the "Worse" side.
4 other companies' latest entry also says "Advanced".
- 2026-07-15AdvancedEarnings
「In China, customers for our Ales needles have secured GPO contracts in several provinces, and shipments under those contracts are scheduled to begin in the fourth quarter of the fiscal year ending August 2026. In Thailand and India, our Ales needles have been selected for new projects by global manufacturers, reflecting customers’ recognition of the strength of our high-quality products.」
The expansion of Ales needle sales has been made concrete through planned shipments under GPO contracts in China and selection for new projects in Thailand and India. - FY2026-H1AdvancedAnnual report
「Sales of ophthalmic knives used in cataract surgery remained stable, particularly in Europe, Japan and North America. However, sales and segment profit grew only modestly, partly because inventory adjustments at distributors in China continued as the number of surgeries was restrained by the country's medical spending policies.」
Regarding sales growth in advanced markets, ophthalmic knives sold steadily in Europe, Japan and North America, and sales of surgical-related products totaled ¥4,880 million, up 3.4% year on year. - FY2025RaisedAnnual report
「Expanding the market share of ophthalmic knives (global share: 30% → 50%)」
We are raising the global market share target for ophthalmic knives from 30% to 50%. - FY2025-H1AdvancedAnnual report
「Sales of surgical-related products totaled ¥4,718 million, up 24.6% year on year, and segment profit was ¥1,643 million, up 32.1%, indicating strong performance.」
Demand for ophthalmic knives expanded in Europe, Asia and North America, including advanced markets, and sales and segment profit from surgical-related products exceeded the levels of the same period of the previous year. - FY2024AdvancedAnnual report
「Sales and profit increased from the same period of the previous year as sales of ophthalmic knives used in cataract surgery and other procedures remained strong in Asia, particularly China, Europe, North America and other regions.」
Sales of ophthalmic knives remained strong in Asia, Europe and North America, including advanced markets, and sales of surgical-related products totaled ¥8,152 million, up 20.2% from the previous fiscal year. - FY2024-Q3AdvancedAnnual report
「Sales and profit increased from the same period of the previous year as sales of ophthalmic knives used in cataract surgery remained strong in Asia, particularly China, Europe, North America and other regions.」
Sales of ophthalmic knives remained strong in Asia, Europe and North America, including advanced markets, and sales of surgical-related products totaled ¥6,001 million, up 18.9% year on year. - FY2024-Q1AdvancedAnnual report
「Sales and profit increased from the same period of the previous year as demand for highly regarded ophthalmic knives expanded in Asia, particularly China, as well as Japan, Europe, North America and other regions.」
Demand for ophthalmic knives expanded in Europe and North America, including advanced markets, and sales of surgical-related products totaled ¥1,945 million, up 18.8% year on year. - FY2023AdvancedAnnual report
「In addition to strong sales of MMG products, including dental restorative materials, in Europe and North America, sales of dental endodontic instruments, such as reamers and files, and dental rotary cutting instruments, such as diamond burs, remained firm in Asia, particularly China and India.」
MMG dental restorative materials and other products performed well in Europe and North America, including advanced markets, providing evidence of progress in expanding product sales in advanced markets. - FY2023-Q3AdvancedAnnual report
「Sales of dental-related products totaled ¥7,023 million, up 15.5% year on year, and segment profit was ¥1,890 million, up 0.1%, as GDF products, including dental restorative materials, performed well in Europe and North America.」
Dental-related products, including GDF products, performed well in Europe and North America, including advanced markets, and sales increased 15.5% year on year. - FY2022-Q3AdvancedAnnual report
「Sales totaled ¥4,388 million, up 20.8% year on year, as sales of highly regarded ophthalmic knives remained strong in Europe, Asia and Japan.」
Sales of ophthalmic knives remained strong in Europe, including advanced markets, and sales of surgical-related products increased 20.8% year on year. - FY2021-Q3Cited as achievedAnnual report
「Sales in Europe at the overseas subsidiary GDF Gesellschaft für dentale Forschung und Innovationen GmbH remained strong.」
In connection with the goal of expanding sales in developed markets, we cite strong European sales at GDF as evidence of progress. - FY2020-Q2RestatedAnnual report
「In addition, we are advancing product development aimed at expanding sales in developed markets」
We continue to pursue the goal of expanding sales in developed markets and product development as the means of achieving it. - FY2019-Q3RestatedAnnual report
「Together with GDF Gesellschaft für dentale Forschung und Innovationen GmbH, our German site, we aim to expand sales of new products in developed markets」
We are maintaining the goal of expanding sales of new products in developed markets. - FY2019-Q2RestatedAnnual report
「Together with GDF Gesellschaft für dentale Forschung und Innovationen GmbH, our German site, we have promoted further technical exchange and information sharing and focused on strengthening new product development, with the aim of expanding sales of new products in developed markets.」
We are maintaining the goal of expanding sales of new products in developed markets and the policy of strengthening new product development as the means of achieving it. - FY2018RestatedAnnual report
「Meanwhile, with regard to expanding sales in advanced markets, we will achieve this goal through the development and launch of new products.」
We are reaffirming the goal of expanding sales in “advanced markets” and using new product development and launches as the means of achieving it. - FY2018-Q3ReframedAnnual report
「We are advancing new product development with the aim of expanding sales in advanced markets.」
The wording has changed from “expanding sales in developed countries” to “expanding sales in advanced markets.” The goal of expanding sales through new product development remains unchanged. - FY2018-Q2RestatedAnnual report
「We have focused on new product development with the aim of expanding sales in developed markets.」
We continue to pursue the policy of targeting sales growth in developed markets and using new product development as the means of achieving it. - FY2018-Q1RestatedAnnual report
「We have focused on new product development with the aim of expanding sales in developed markets.」
We continue to pursue the policy of targeting sales growth in developed markets and using new product development as the means of achieving it. - FY2017RestatedAnnual report
「Meanwhile, with regard to expanding sales in developed markets, we will achieve this goal through the development and launch of new products.」
We are maintaining the policy of targeting sales growth in developed markets and using new product development and launches as the means of achieving it. - FY2017-Q3RestatedAnnual report
「We are advancing new product development with the aim of expanding sales in developed markets.」
We continue to pursue the goal of expanding sales in developed markets and new product development as the means of achieving it. - FY2017-Q2RestatedAnnual report
「We have focused on new product development with the aim of expanding sales in developed markets.」
We continue to pursue the goal of expanding sales in developed markets and new product development as the means of achieving it. - FY2017-Q1RestatedAnnual report
「We have focused on new product development with the aim of expanding sales in developed markets.」
We continue to pursue the goal of expanding sales in developed markets and new product development as the means of achieving it. - FY2016RestatedAnnual report
「Meanwhile, with regard to expanding sales in developed markets, we will promote sales and marketing activities at SDG, our German subsidiary, and achieve this goal by developing and launching new products on a scale far exceeding that of the past.」
We are maintaining the goal of expanding sales in developed markets and have identified sales and marketing at SDG and new product launches as the means of achieving it. - FY2016-Q3First statedAnnual report
「We are advancing new product development with the aim of expanding sales in developed markets.」
We have set sales growth in developed markets as a goal and are pursuing new product development as the means of achieving it.